相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The therapeutic potential of attenuated diphtheria toxin delivered by an adenovirus vector with survivin promoter on human lung cancer cells
Lvxia Dai et al.
CANCER BIOLOGY & THERAPY (2021)
EGFR-mediated Rad51 expression potentiates intrinsic resistance in prostate cancer via EMT and DNA repair pathways
Mohit Rajput et al.
LIFE SCIENCES (2021)
Mitogen-activated protein kinase inhibition-induced modulation of epidermal growth factor receptor signaling in human head and neck squamous cell carcinoma
Guiqin Xie et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2021)
Potent in vitro antitumor activity of B-subunit of Shiga toxin conjugated to the diphtheria toxin against breast cancer
Zeinab Mohseni et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Effect of Diphtheria Toxin-Based Gene Therapy for Hepatocellular Carcinoma
Kenya Kamimura et al.
CANCERS (2020)
Erlotinib sensitivity of MAPK1p.D321N mutation in head and neck squamous cell carcinoma
Hoi-Lam Ngan et al.
NPJ GENOMIC MEDICINE (2020)
Targeting Receptors on Cancer Cells with Protein Toxins
Antonella Antignani et al.
BIOMOLECULES (2020)
Head and neck squamous cell carcinoma
Daniel E. Johnson et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
Inhibition of MEK suppresses hepatocellular carcinoma growth through independent MYC and BIM regulation
Xiqiao Zhou et al.
CELLULAR ONCOLOGY (2019)
Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer
Hyung Kwon Byeon et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases
Weili Sun et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Tolerogenic nanoparticles restore the antitumor activity of recombinant immunotoxins by mitigating immunogenicity
Ronit Mazor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Use of the XRCC2 promoter for in vivo cancer diagnosis and therapy
Yu Chen et al.
CELL DEATH & DISEASE (2018)
New developments in the management of head and neck cancer - impact of pembrolizumab
Khalil Saleh et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2018)
How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?
Brandon J. Aubrey et al.
CELL DEATH AND DIFFERENTIATION (2018)
Epidemiological Trends of Head and Neck Cancer in the United States: A SEER Population Study
Moustafa Mourad et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2017)
Recombinant Immunotoxin Therapy of Glioblastoma: Smart Design, Key Findings, and Specific Challenges
Shaowei Zhu et al.
BIOMED RESEARCH INTERNATIONAL (2017)
EGFR-targeted therapies in the post-genomic era
Mary Jue Xu et al.
CANCER AND METASTASIS REVIEWS (2017)
Hypoxia-inducible tumour-specific promoters as a dual-targeting transcriptional regulation system for cancer gene therapy
Bita Javan et al.
ECANCERMEDICALSCIENCE (2017)
Probe-free allele-specific copy number detection and analysis of tumors
Ailin Zhu et al.
ANALYTICAL BIOCHEMISTRY (2016)
MAPK1E322K mutation increases head and neck squamous cell carcinoma sensitivity to erlotinib through enhanced secretion of amphiregulin
Yihui Wen et al.
ONCOTARGET (2016)
A bivalent recombinant immunotoxin with high potency against tumors with EGFR and EGFRvIII expression
Jie Meng et al.
CANCER BIOLOGY & THERAPY (2015)
PET Imaging in Head and Neck Cancer Patients to Monitor Treatment Response: A Future Role for EGFR-Targeted Imaging
Laura K. van Dijk et al.
CLINICAL CANCER RESEARCH (2015)
Cell Death Signaling
Douglas R. Green et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2015)
Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma
Eliezer M. Van Allen et al.
JAMA ONCOLOGY (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
In Vitro and In Vivo Activity of the Low-Immunogenic Antimesothelin Immunotoxin RG7787 in Pancreatic Cancer
Kevin Hollevoet et al.
MOLECULAR CANCER THERAPEUTICS (2014)
ADP-ribosylation of Translation Elongation Factor 2 by Diphtheria Toxin in Yeast Inhibits Translation and Cell Separation
Maria K. Mateyak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Targeting of a Conformationally Exposed, Tumor-Specific Epitope of EGFR as a Strategy for Cancer Therapy
Hui K. Gan et al.
CANCER RESEARCH (2012)
The RNA polymerase II CTD coordinates transcription and RNA processing
Jing-Ping Hsin et al.
GENES & DEVELOPMENT (2012)
Phase I Trial of Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox (CAT-8015 or HA22) in Patients With Hairy Cell Leukemia
Robert J. Kreitman et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
EGFR-Targeted Therapy in Malignant Glioma: Novel Aspects and Mechanisms of Drug Resistance
Hui-Wen Lo
Current Molecular Pharmacology (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Salvianolic acid B inhibits growth of head and neck squamous cell carcinoma in vitro and in vivo via cyclooxygenase-2 and apoptotic pathways
Yubin Hao et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Engineering and Biological Characterization of VB6-845, an Anti-EpCAM Immunotoxin Containing a T-cell Epitope-depleted Variant of the Plant Toxin Bouganin
Jeannick Cizeau et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Antibodies specifically targeting a locally misfolded region of tumor associated EGFR
Thomas P. J. Garrett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Molecular Target Approaches in Head and Neck Cancer: Epidermal Growth Factor Receptor and Beyond
Paul M. Harari et al.
SEMINARS IN RADIATION ONCOLOGY (2009)
Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma - Predictive and prognostic correlation
Susan Muller et al.
CANCER (2008)
Vitamin E succinate induces ceramide-mediated apoptosis in head and neck squamous cell carcinoma in vitro and in vivo
Xinbin Gu et al.
CLINICAL CANCER RESEARCH (2008)
An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopes
Masanori Onda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
S. Fulda et al.
ONCOGENE (2006)
Blockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiorsensitivity of K-RAS mutated human tumor cells in vitro by affecting DNA repair
Mahmoud Toulany et al.
CLINICAL CANCER RESEARCH (2006)
A β-lactamase with reduced immunogenicity for the targeted delivery of chemotherapeutics using antibody-directed enzyme prodrug therapy
FA Harding et al.
MOLECULAR CANCER THERAPEUTICS (2005)
C-terminal repeat domain kinase I phosphorylates Ser2 and Ser5 of RNA polymerase IIC-terminal domain repeats
JC Jones et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Quality-of-life improvements in cutaneous T-cell lymphoma patients treated with denileukin diftitox (ONTAK (R))
M Duvic et al.
CLINICAL LYMPHOMA (2002)
Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma
E Olsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Phase I trial of recombinant immunotoxin anti-Tac(Fv)PE38 (LMB-2) in patients with hematologic malignancies
RJ Kreitman et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
